NCT01679990

Phase 2Interventional

Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.

View on ClinicalTrials.gov ↗

Timeline

Start date: Oct 1, 2012
Primary completion: Apr 1, 2018
Completion date: Apr 1, 2018
First posted: —
Last posted: —
Enrollment: 172
Arms / groups: 4 / —
Source: AACT · pre-existing

Sponsors

Pluristem Ltd.Lead sponsor
Cha Medical UniversityOverall official - principal investigator
Korea UniversityOverall official - principal investigator
Kangbuk Samsung HospitalOverall official - principal investigator
Ilsan HospitalOverall official - principal investigator
Duke UniversityOverall official - principal investigator
University of KentuckyOverall official - principal investigator
University of MinnesotaOverall official - principal investigator
Clinical Trials of Texas, IncOverall official - principal investigator
Aiyan Diabetes Center, Evans, GAOverall official - principal investigator
University of HeidelbergOverall official - principal investigator
DMI Research, Pinellas Park FLOverall official - principal investigator
Turkey Creek Medical Center, KnoxvilleOverall official - principal investigator
Ajou UniversityOverall official - principal investigator
University of PennsylvaniaOverall official - principal investigator
Dong-A UniversityOverall official - principal investigator
Hallym UniversityOverall official - principal investigator
Tampa Bay Medical ResearchOverall official - principal investigator
Florida Research NetworkOverall official - principal investigator
Franziskus Hospital, BerlinOverall official - principal investigator
University of HamburgOverall official - principal investigator
Omega Medical ResearchOverall official - principal investigator
Tel Aviv UniversityOverall official - principal investigator
Icahn School of Medicine at Mount SinaiOverall official - principal investigator
Pusan National UniversityOverall official - principal investigator

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.